1
Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition(s):Attention Deficit Hyperactivity Disorder (ADHD)Last Updated:June 8, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Attention Deficit Hyperactivity Disorder (ADHD)Last Updated:June 8, 2021Completed
Condition(s):Attention Deficit Disorder With HyperactivityLast Updated:June 24, 2021Completed
Condition(s):Attention Deficit Disorder With HyperactivityLast Updated:June 30, 2021Completed
Condition(s):Attention Deficit Disorder With HyperactivityLast Updated:August 23, 2021Completed
Condition(s):Attention Deficit Disorder With HyperactivityLast Updated:July 13, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.